Skip to content

Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery in Elderly Laparoscopic Patients

Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery in Elderly Laparoscopic Patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089877
Enrollment
Unknown
Registered
2024-09-18
Start date
2023-07-21
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Application of cyclophenol in elderly patients

Interventions

Cyprofol group:Anesthesia induction: Cyprofol injection group (drug name: Cyprofol injection, drug specification: 20ml: 50mg, drug batch number: H20200013, manufacturer: Liaoning Haisike Pharmaceutica
Propofol group:Anesthesia induction: Propofol group (drug name: Propofol medium/long chain fat emulsion injection, drug specification: 20ml: 0.2g, drug batch number: H20203504, manufacturer: Jiangsu Y

Sponsors

Anesthesiology Department, Guiyang First People's Hospita
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1) The patient is aged 60-79 years old, regardless of gender; 2) The American Society of Anesthesiologists (ASA) health status classification is grades I-II; 3) Those who plan to undergo laparoscopic surgery under three-level surgical management; 4) Body mass index (BMI): 18-30 kg/m2; 5) Those who can understand the trial protocol and have the patient or legal representative sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients who have taken penehyclidine hydrochloride and scopolamine within 2 weeks before surgery; 2) Those with difficulty in airway estimation; 3) Patients with chronic pain, long-term use of analgesic and sedative drugs, or a history of drug abuse; 4) Those who are known to be allergic to the study medication and excipients, have deep sedation or anesthesia contraindications, or have previously experienced sedation/anesthesia accidents; 5) Those who suffer from mental illness or neurological disease; 6) Participated in other clinical trials as a subject in the past 3 months.

Design outcomes

Primary

MeasureTime frame
The Scale Scores of Recovery Quality-15 ;

Countries

China

Contacts

Public ContactWang LeiLei

Anesthesiology Department, Guiyang First People's Hospita

1312714135@qq.com+86 130 0578 5872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026